Celldex Therapeutics (CLDX) EBIT Margin (QoQ) (2010 - 2026)
Powered by 
Analysis
Celldex Therapeutics (CLDX) EBIT Margin (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Celldex Therapeutics | 3.10 Bn | 3.10 Bn | -2.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.64 Mn |
| Mar 31, 2026 | -49.09 Mn |
| Jun 30, 2025 | 27,966.00 |
| Mar 31, 2025 | -425,894.00 |
| Dec 31, 2024 | -313,472.00 |
| Sep 30, 2024 | 22,063.00 |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | -2.49 Mn |
| Dec 31, 2023 | 156,554.00 |
| Sep 30, 2023 | 967,147.00 |
| Jun 30, 2023 | -903,201.00 |
| Mar 31, 2023 | -162,914.00 |
| Dec 31, 2022 | 507,615.00 |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | -896,274.00 |
| Mar 31, 2022 | -727,627.00 |
| Dec 31, 2021 | 752,064.00 |
| Sep 30, 2021 | -1.32 Mn |
| Jun 30, 2021 | 204,284.00 |
| Mar 31, 2021 | -177,451.00 |